Neutropenia Induced by Second Generation Antipsychotics: A Prospective Investigation

Abstract

Background: Clozapine is known to induce neutropenia as well as agranulocytosis. Some cases of olanzapine- and risperidone-induced neutropenia and agranulocytosis have also been reported. We prospectively investigated schizophrenia patients treated with second generation antipsychotics with respect to alterations of white blood cell counts.

Methods: In an analysis of our drug monitoring program, we studied white blood cell counts in 104 patients receiving different second generation antipsychotics other than clozapine for at least six months and compared them with those of 28 patients receiving clozapine.

Results: We found neutropenia (neutrophils <2 000/μL) in the mixed group in 17.6% and in 11.8% of patients treated with clozapine during the first 6 months. There was no statistically significant difference between those groups with respect to the risk to develop neutropenia during the investigation period. There was no case of agranulocytosis. Neutropenia was transient in all patients. Eosinophilia occurred in some patients that developed neutropenia later on but had no significant predictive value.

References

• 1 Amar A, Segman RH, Shtrussberg S. et al . An association between clozapine-induced agranulocytosis in schizophrenics and HLA-DQB1*0201.  Int J Neuropsychopharmacol. 1998;  1 41-44
• 2 Ames D, Wirshing WC, Baker RW. et al . Predictive value of eosinophilia for neutropenia during clozapine treatment.  J Clin Psychiatry. 1996;  57 579-581
• 3 Benedetti F, Cavallaro R, Smeraldi E. Olanzapine-induced neutropenia after clozapine-induced neutropenia.  Lancet. 1999;  354 567
• 4 Buchman N, Strous RD, Ulman AM. et al . Olanzapine-induced leucopenia with human leucocyte antigen profiling.  Int Clin Psychopharmacol. 2001;  16 55-57
• 5 Claas FH, Abbott PA, Witvliet MD. et al . No direct clinical relevance of the human leucocyte antigen (HLA) system in clozapine-induced agranulocytosis.  Drug Saf. 1992;  7 ((Suppl 1)) 3-6
• 6 Etain B, Roubaud L, Le Heuzey MF. et al . Un cas de leucopenia sous tretement par risperidone chez un adolescent.  Encephale. 2000;  26 81-84
• 7 Gerson SL. G-CSF and the management of clozapine-induced agranulocytosis.  J Clin Psychiatry. 1994;  55 ((Suppl B)) 139-142 [Review]
• 8 Godleski LS, Sernyak MJ. Agranulocytosis after addition of risperidone to clozapine treatment.  Am J Psychiatry. 1996;  153 735-736
• 9 Grohmann R, Rüther E, Sassim N. et al . Adverse effects of clozapine.  Psychopharmacology. 1989;  99 101-104
• 10 Hofer A, Rettenbacher MA, Edlinger M. et al . Outcomes in schizophrenia patients treated with amisulpride or olanzapine.  Pharmacopsychiatry. 2007;  40 1-8
• 11 Hummer M, Kurz M, Barnas C. et al . Transient neutropenia induced by clozapine.  Psychopharmacol Bull. 1992;  28 287-290
• 12 Hummer M, Kurz M, Barnas C. et al . Clozapine-induced transient white blood count disorders.  J Clin Psychiatry. 1994;  55 429-432
• 13 Hummer M, Sperner-Unterweger B, Kemmler G. et al . Does eosiniophilia predict clozapine-induced neutropenia?.  Psychopharmacology (Berl). 1996;  124 201-204
• 14 Kodesh A, Finkel B, Lerner AG. et al . Dose dependent olanzapine-associated leucopenia: three case reports.  Int Clin Psychopharmacol. 2001;  16 117-119
• 15 Konakanchi R, Grace JJ, Szarowicz R. et al . Olanzapine induced prolongation of granulocytopenia after clozapine discuntination.  J Clin Psychopharmacol. 2000;  20 703-704
• 16 Krupp P, Barnes P. Leponex-associated granulocytopenia: a review of the situation.  Psychopharmacology (Berl). 1989;  99 118-121
• 17 Lieberman JA, Alvir JM. A report of clozapine-induced agranulocytosis in the United States. Incidence and risk factors.  Drug Saf. 1992;  7 1-2
• 18 Melkersson K, Dahl ML. Adverse metabolic side effects associated with atypical antipsychotics: literature review and clinical implications.  Drugs. 2004;  64 701-723 [Review]
• 19 Ruhe HG, Becker HE, Jessurun P. et al . Agranulocytosis and granulocytopenia associated with quetiapine.  Acta Psychiatr Scand. 2001;  104 311-313 discussion: 313–314
• 20 Schuld A, Kraus T, Hinze-Selch D. et al . Granulocyte colony-stimulating factor plasma levels during clozapine- and planzapine-induced granulocytopenia.  Acta Psychiatr Scand. 2000;  102 153-155
• 21 Sperner-Unterweger B, Czeipek I, Gaggl S. et al . Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF). Remission despite continuous treatment with clozapine.  Br J Psychiatry. 1998;  172 82-84
• 22 Steinwachs A, Grohmann R, Pedrosa F. et al . Two cases of Olanzapine-induced neutropenia.  Pharmacopsychiatry. 1999;  32 154-156
• 23 Stübner S, Grohmann R, Engel R. et al . Blood dyscrasias induced by psychotropic drugs.  Pharmacopsychiatry. 2004;  37 ((Suppl 1)) S70-S78

Correspondence